Literature DB >> 30693605

MRI and MRS of intact perfused cancer cell metabolism, invasion, and stromal cell interactions.

Marie-France Penet1,2, Tariq Shah1, Flonne Wildes1, Balaji Krishnamachary1, Santosh K Bharti1, Jesus Pacheco-Torres1, Dmitri Artemov1,2, Zaver M Bhujwalla1,2,3.   

Abstract

Because of the spatial and temporal heterogeneities of cancers, technologies to investigate cancer cells and the consequences of their interactions with abnormal physiological environments, such as hypoxia and acidic extracellular pH, with stromal cells, and with the extracellular matrix, under controlled conditions, are valuable to gain insights into the functioning of cancers. These insights can lead to an understanding of why cancers invade and metastasize, and identify effective treatment strategies. Here we have provided an overview of the applications of MRI/MRS/MRSI to investigate intact perfused cancer cells, their metabolism and invasion, and their interactions with stromal cells and the extracellular matrix.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  hypoxia; intact cancer cells; invasion; metabolism; perfusion; stromal cells

Mesh:

Year:  2019        PMID: 30693605      PMCID: PMC6661227          DOI: 10.1002/nbm.4053

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  66 in total

1.  Noninvasive imaging identifies new roles for cyclooxygenase-2 in choline and lipid metabolism of human breast cancer cells.

Authors:  Tariq Shah; Ioannis Stasinopoulos; Flonne Wildes; Samata Kakkad; Dmitri Artemov; Zaver M Bhujwalla
Journal:  NMR Biomed       Date:  2011-09-22       Impact factor: 4.044

2.  Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor.

Authors:  Kayvan R Keshari; David M Wilson; Mark Van Criekinge; Renuka Sriram; Bertram L Koelsch; Zhen J Wang; Henry F VanBrocklin; Donna M Peehl; Tom O'Brien; Deepak Sampath; Richard A D Carano; John Kurhanewicz
Journal:  Prostate       Date:  2015-07-14       Impact factor: 4.104

3.  Intracellular volume and apparent diffusion constants of perfused cancer cell cultures, as measured by NMR.

Authors:  U Pilatus; H Shim; D Artemov; D Davis; P C van Zijl; J D Glickson
Journal:  Magn Reson Med       Date:  1997-06       Impact factor: 4.668

4.  Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells.

Authors:  Matthew Milkevitch; Hyunsuk Shim; Ulrich Pilatus; Stephen Pickup; Janna P Wehrle; Dvorit Samid; Harish Poptani; Jerry D Glickson; Edward J Delikatny
Journal:  Biochim Biophys Acta       Date:  2005-02-24

5.  Toxicity and effects of epidermal growth factor on glucose metabolism of MDA-468 human breast cancer cells.

Authors:  O Kaplan; J W Jaroszewski; P J Faustino; G Zugmaier; B W Ennis; M Lippman; J S Cohen
Journal:  J Biol Chem       Date:  1990-08-15       Impact factor: 5.157

Review 6.  Phospholipases in biology and medicine.

Authors:  E Kaiser; P Chiba; K Zaky
Journal:  Clin Biochem       Date:  1990-10       Impact factor: 3.281

7.  Growth of a human colonic adenocarcinoma cell line (HT 29) on microcarrier beads: metabolic studies by 31phosphorus nuclear magnetic resonance spectroscopy.

Authors:  J Fantini; J P Galons; J Marvaldi; P J Cozzone; P Canioni
Journal:  Int J Cancer       Date:  1987-02-15       Impact factor: 7.396

8.  Imaging intratumoral convection: pressure-dependent enhancement in chemotherapeutic delivery to solid tumors.

Authors:  Terence P F Gade; Ian M Buchanan; Matthew W Motley; Yousef Mazaheri; William M Spees; Jason A Koutcher
Journal:  Clin Cancer Res       Date:  2009-01-01       Impact factor: 12.531

9.  NMR-based evaluation of the metabolic profile and response to dichloroacetate of human prostate cancer cells.

Authors:  Mithun Kailavasan; Ishtiaq Rehman; Steven Reynolds; Adriana Bucur; Gillian Tozer; Martyn Paley
Journal:  NMR Biomed       Date:  2014-03-17       Impact factor: 4.044

10.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.